Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents

Clinical and Experimental Immunology

Volumn 118, Issue SUPPL. 1, 1999, Pages 29-34

  Chapel, Helen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HEPATITIS A VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOTHERAPY; PARVOVIRUS; PRIORITY JOURNAL; SCREENING TEST; VIRUS INACTIVATION; VIRUS TRANSMISSION;

BLOOD; BLOOD SPECIMEN COLLECTION; BLOOD-BORNE PATHOGENS; CONSUMER PRODUCT SAFETY; CREUTZFELDT-JAKOB SYNDROME; GUIDELINES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; VIRUS DISEASES;

EID: 0032857009     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00000.x     Document Type: Article

References (6)

1. Milgrom H. Shortages of intravenous immunoglobulin. Ann Allergy, Asthma Immunol 1998;81:97-9.
2. Cohn EJ, Strong LE, Hughes WL et al. Preparation and properties of serum and plasma proteins IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. Ann Am Chem Soc Year 1946;68:459-75.
3. Yap PL. Viral Safety of IVIg. In: Intravenous Immunoglobulin in Clinical Practice (eds Lee M, Strand V) Marcel Dekker 1997 pp 67-106.
4. Mitra G, Wong MF, Mozen MM, McDougal FS, Levy JA. Elimination of infectious retroviruses during preparation of immunoglobulin. Transfusion 1986;26:394-7.
5. Wells MA, Wittek AE, Epstein JS et al. Inactivation and partition of human T cell lymphotrophic virus, type III, during ethanol fractionation of plasma. Transfusion 1986;26:210-3.
6. Center for Disease Control. Safety of therapeutic immunoglobulin presss with respect to transmission of human T lymphocyte virus type I/lymphadenopathy associated virus infection. MMWR 1986;35:231-2.